HIV
HIV Risk Reduced in Carriers of Allele Linked to Severe COVID-19
HIV infection risk was roughly 27 percent lower in individuals with a COVID-19 risk allele that reduced CCR5 chemokine receptor gene expression.
HIV Sequencing Study in Netherlands Uncovers Virulent Variant Mutations, History
Along with analyses focused on de novo mutations contributing to virulence and transmissibility, researchers traced the HIV-1 VB variant back to at least the early 1990s.
Florida Atlantic University Wins $1.3M NIH Grant to Develop Sample-to-Answer HIV Self-Test
The assay will be designed for self-testing and is expected to be sensitive enough to detect HIV during acute infection, treatment, and viral rebound.
Roche Infectious Disease Tests for New Molecular Instrument Nab CE Mark
They are the first four assays launched for the Cobas 5800 platform, and Roche is pursuing CE marking for other tests, including the Cobas SARS-CoV-2 test.
Cepheid Nabs CE Mark for PCR-Based HIV-1 Tests
Both tests run on any of the firm's GeneXpert systems and add second targets for HIV detection and early identification.
May 7, 2020
Grifols ART System Nabs FDA Approval
May 6, 2020
OraSure Technologies Q1 Revenues Rise 5 Percent
Feb 19, 2020
OraSure Technologies Q4 Revenues Down 1 Percent
Jan 30, 2020
Nov 7, 2019